Insiders Galectin Therapeutics Inc.

Equities

GALT

US3632252025

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.45 ^USD	-1.43%		+2.37%	+107.83%

Mar. 29	Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors	CI
Mar. 29	Galectin Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors	Mar. 29	CI
Galectin Therapeutics Inc. Announces Board Appointments	21-08-30	CI
Insider Trends: Galectin Therapeutics Insider Sale Interrupting 90-Day Buy Trend	21-05-04	MT
Galectin Therapeutics Inc. Announces Executive Changes	21-04-19	CI
Insider Trends: Galectin Therapeutics Insider Extends 90-Day Selling Trend	21-01-19	MT
Galectin Therapeutics Appoints Joel Lewis as President	20-09-02	CI
Galectin Therapeutics, Inc. Announces Management Changes	20-09-02	CI
Galectin Therapeutics, Inc. Appoints Pol F. Boudes as Chief Medical Officer	20-05-11	CI
Galectin Therapeutics Inc. Appoints Pol F. Boudes as Chief Medical Officer, Effective from March 2, 2020	20-02-20	CI
10X Capital Intends to Nominate Candidate to the Board of Galectin Therapeutics	19-04-01	CI
Galectin Therapeutics, Inc. Announces Executive Changes	18-06-12	CI
Galectin Therapeutics Inc. Announces Management Appointments	18-06-04	CI
Galectin Therapeutics, Inc. Elects Kary Eldred as Director	18-05-29	CI
Galectin Therapeutics Inc. Announces Credit Line from Richard E. Uihlein; Appoints Richard E. Uihlein to the Board of Directors	17-12-19	CI
Galectin Therapeutics, Inc. Approves the Election of Stephen Shulman as Director	17-12-19	CI
Galectin Therapeutics CEO Peter G. Traber, M.D. Named Chair of the Anti-Fibrotic Drug Development Summit 2017	17-11-13	GL
Galectin Therapeutics CEO Peter G. Traber, M.D. Named Chair of the Conference for NASH Summit Europe 2017	17-09-25	GL
Peter G. Traber Intends Not to Stand for Re-Election to the Board at the AGM of Galectin Therapeutics, Inc	17-09-22	CI
Galectin Therapeutics Appoints Dr. Marc Rubin as Chairman of the Board of Directors	16-01-08	CI
Galectin Therapeutics Inc. Appoints Adam E. Allgood, Pharm.D., R.Ph., as Executive Director of Clinical Development	15-07-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Galectin Therapeutics Inc.

Equities

GALT

US3632252025

Insiders

Filters